Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Quality of Life, Safety and Tolerability of Prucalopride in Male Subjects With Chronic Constipation

NCT01147926 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01147926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01147926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Quality of Life, Safety and Tolerability of Prucalopride in Male Subjects With Chronic Constipation
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
September 23, 2010
Completion date
October 25, 2013
Enrollment
374 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

male subjects with chronic constipation